CLINICAL_TRIALS
trial_result
· 2018-08-01
Clinical Trial Update: First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK3389404 in Healthy Subjects [Phase 1]
Summary
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of GSK3389404 in healthy subjects completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 1 | Status: COMPLETED | Results posted: 2018-08-01